Survival Rates for Patients With Barrett High-grade Dysplasia and Esophageal Adenocarcinoma With or Without Human Papillomavirus Infection
Open Access
- 3 August 2018
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 1 (4) , e181054
Abstract
Esophageal adenocarcinoma (EAC) is one of the fastest-growing and deadliest cancers in the Western world,1,2 although recently the rate of increase has diminished and possibly plateaued in the United States and Sweden.3,4 Currently, Barrett esophagus (BE) is the only recognized visible precursor lesion for EAC. Intriguingly, these high rates of EAC have occurred against a backdrop of progressive reduction in the risk estimate of malignancy associated with BE.5 In this regard, our discovery of a strong association of transcriptionally active high-risk human papillomavirus (HPV) with a subset of Barrett dysplasia (BD) and EAC5 may be relevant.Keywords
This publication has 38 references indexed in Scilit:
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 2011
- Human papillomavirus is detectable in Barrett's esophagus and esophageal carcinoma but is unlikely to be of any etiologic significanceJournal of Clinical Virology, 2011
- No further increase in the incidence of esophageal adenocarcinoma in SwedenInternational Journal of Cancer, 2010
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Human papillomavirus infection in Barrett's oesophagus in the UK: An infrequent eventJournal of Clinical Virology, 2008
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI: Journal of the National Cancer Institute, 2008
- TP53Mutations and Survival in Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2007
- Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta‐analysisInternational Journal of Cancer, 2007
- Reversal of cisplatin resistance with a BH3 mimetic, (−)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xLMolecular Cancer Therapeutics, 2005
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998